
Daily Briefing
FDA has approved a new treatment from Revolution Medicines that could transform pancreatic cancer care, significantly extending the lives of patients with the disease, in today’s bite-sized hospital and health industry news from Maryland, Massachusetts, and Washington.
August 27, 2026






